Provided by Tiger Fintech (Singapore) Pte. Ltd.

Janux Therapeutics, Inc.

29.69
+1.003.49%
Post-market: 29.690.00000.00%19:52 EDT
Volume:367.18K
Turnover:10.83M
Market Cap:1.75B
PE:-23.13
High:29.82
Open:28.80
Low:28.60
Close:28.69
Loading ...
Jul 19, 2023

Major Issues Report

Form 8-K - Current report
Jul 17, 2023

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jul 17, 2023

Major Issues Report

Form 8-K - Current report
Jul 10, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 24, 2023

Major Issues Report

Form 8-K - Current report
Jun 21, 2023

Major Issues Report

Form 8-K - Current report
May 31, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
May 09, 2023

Major Issues Report

8-K - Current report
May 09, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2023

Major Issues Report

8-K - Current report
Mar 31, 2023

Major Issues Report

8-K - Current report
Mar 10, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 10, 2023

Major Issues Report

8-K - Current report
Mar 10, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 23, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 10, 2022

Major Issues Report

8-K - Current report
Nov 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 22, 2022

Major Issues Report

8-K - Current report
Sep 15, 2022

Correspondence

CORRESP [Cover] - Correspondence